Travere Therapeutics (TVTX) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of$0.55. This compares to loss of $1.76 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 14.55$0.58 per share when it actually produced a loss of $0.73, delivering a surprise of -25.86%.Over the last four quarters, the company ...